Brian C. Shook,In Jong Kim,Jianming Yu,Thomas P. Blaisdell,Joseph Panarese,Yat Sun Or
申请号：
US15863216
公开号：
US20180193352A1
申请日:
2018.01.05
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof:These compounds are useful for treating Respiratory Syncytial Virus (RSV) infection. The present invention further relates to pharmaceutical compositions comprising these compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering to the subject a pharmaceutical composition comprising a compound of the invention.
